Integrating ion mobility spectrometry into mass spectrometry-based exposome measurements: What can it add and how far can it go?

Bioanalysis

Volumn 9, Issue 1, 2017, Pages 81-98

  Metz, Thomas O ^a   Baker, Erin S ^a   Schymanski, Emma L ^b   Renslow, Ryan S ^a   Thomas, Dennis G ^a   Causon, Tim J ^c   Webb, Ian K ^a   Hann, Stephan ^c   Smith, Richard D ^a   Teeguarden, Justin G ^a,d  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

collision cross section; exposome; ion mobility spectrometry; mass spectrometry; metabolome

Indexed keywords

ANALYTIC METHOD; EXPOSURE; ION MOBILITY SPECTROMETRY; MASS SPECTROMETRY; METABOLITE; METABOLOME; PHYSICAL CHEMISTRY; ANIMAL; BIOLOGY; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; PROCEDURES; WORKFLOW;

ANIMALS; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MASS SPECTROMETRY; METABOLOME; WORKFLOW;

EID: 85002834076     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio-2016-0244     Document Type: Article

References (125)

1. Wild CP. Complementing the genome with an 'exposome': The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14(8), 1847-1850 (2005).
2. Wild CP. The exposome: from concept to utility. Int. J. Epidemiol. 41(1), 24-32 (2012).
3. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat. Rev. Genet. 11(4), 259-272 (2010).
4. Norris SL, Nichols PJ, Caspersen CJ et al. The effectiveness of disease and case management for people with diabetes: A systematic review. Am. J. Prev. Med. 22(4), 15-38 (2002).
5. Committee on Human and Environmental Exposure Science in the 21st Century. Exposure Science in the 21st Century: A Vision and a Strategy. The National Academies Press, Washington, DC (2012).
6. Weis BK, Balshaw D, Barr JR et al. Personalized exposure assessment: promising approaches for human environmental health research. Environ. Health Perspect. 113(7), 840-848 (2005).
7. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ. Xenobiotic metabolomics: major impact on the metabolome. Annu. Rev. Pharmacol. Toxicol. 52, 37-56 (2012).
8. Bundy JG, Davey MP, Viant MR. Environmental metabolomics: A critical review and future perspectives. Metabolomics 5(1), 3-21 (2008).
9. Vineis P, Khan AE, Vlaanderen J, Vermeulen R. The impact of new research technologies on our understanding of environmental causes of disease: The concept of clinical vulnerability. Environ. Health 8, 54 (2009).
10. Athersuch T. Metabolome analyses in exposome studies: profiling methods for a vast chemical space. Arch. Biochem. Biophys. 589, 177-186 (2016).
11. Ruddigkeit L, Awale M, Reymond JL. Expanding the fragrance chemical space for virtual screening. J. Cheminform. 6, 27 (2014).
12. O'hagan S, Kell DB. Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites. Front. Pharmacol. 6, 105 (2015).
13. Wishart DS. Advances in metabolite identification. Bioanalysis 3(15), 1769-1782 (2011).
14. Menikarachchi LC, Hill DW, Hamdalla MA, Mandoiu II, Grant DF. In silico enzymatic synthesis of a 400, 000 compound biochemical database for nontargeted metabolomics. J. Chem. Inf. Model. 53(9), 2483-2492 (2013).
15. Peironcely JE, Reijmers T, Coulier L, Bender A, Hankemeier T. Understanding and classifying metabolite space and metabolite-likeness. PLoS ONE 6(12), e28966 (2011).
16. Senko MW, Beu SC, Mclaffertycor FW. Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions. J. Am. Soc. Mass Spectrom. 6(4), 229-233 (1995).
17. Metz TO, Zhang Q, Page JS et al. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark. Med. 1(1), 159-185 (2007).
18. Stein SE, Ausloos P, Lias SG. Comparative evaluations of mass spectral databases. J. Am. Soc. Mass Spectrom. 2(5), 441-443 (1991).
19. Ausloos P, Clifton CL, Lias SG et al. The critical evaluation of a comprehensive mass spectral library. J. Am. Soc. Mass Spectrom. 10(4), 287-299 (1999).
20. Smith CA, O'maille G, Want EJ et al. METLIN: A metabolite mass spectral database. Ther. Drug Monit. 27(6), 747-751 (2005).
21. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78(13), 4430-4442 (2006).
22. Kind T, Wohlgemuth G, Lee DY et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal. Chem. 81(24), 10038-10048 (2009).
23. Kind T, Liu KH, Lee Do Y, Defelice B, Meissen JK, Fiehn O. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods 10(8), 755-758 (2013).
24. Bocker S, Rasche F. Towards de novo identification of metabolites by analyzing tandem mass spectra. Bioinformatics 24(16), i49-i55 (2008).
25. Brouard C, Shen H, Duhrkop K, D'alche-Buc F, Bocker S, Rousu J. Fast metabolite identification with Input Output Kernel Regression. Bioinformatics 32(12), i28-i36 (2016).
26. Duhrkop K, Shen H, Meusel M, Rousu J, Bocker S. Searching molecular structure databases with tandem mass spectra using CSI:FingerID. Proc. Natl Acad. Sci. USA 112(41), 12580-12585 (2015).
27. Jeffryes JG, Colastani RL, Elbadawi-Sidhu M et al. MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics. J. Cheminform. 7, 44 (2015).
28. Horai H, Arita M, Kanaya S et al. MassBank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 45(7), 703-714 (2010).
29. Wolf S, Schmidt S, Muller-Hannemann M, Neumann S. In silico fragmentation for computer assisted identification of metabolite mass spectra. BMC Bioinformatics 11, 148 (2010).
30. Gerlich M, Neumann S. MetFusion: integration of compound identification strategies. J. Mass Spectrom. 48(3), 291-298 (2013).
31. Allen F, Pon A, Wilson M, Greiner R, Wishart D. CFMID: A web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucleic Acids Res. 42, W94-W99 (2014).
32. Eng JK, Mccormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5(11), 976-989 (1994).
33. Craig R, Beavis RC. A method for reducing the time required to match protein sequences with tandem mass spectra. Rapid Commun. Mass Spectrom. 17(20), 2310-2316 (2003).
34. Kim S, Gupta N, Pevzner PA. Spectral probabilities and generating functions of tandem mass spectra: A strike against decoy databases. J. Proteome Res. 7(8), 3354-3363 (2008).
35. Altman DG, Bland JM. Diagnostic tests. 1: sensitivity and specificity. BMJ 308(6943), 1552 (1994).
36. Cortejade A, Kiss A, Cren C, Vulliet E, Bulete A. Development of an analytical method for the targeted screening and multi-residue quantification of environmental contaminants in urine by liquid chromatography coupled to high resolution mass spectrometry for evaluation of human exposures. Talanta 146, 694-706 (2016).
37. Davie-Martin CL, Hageman KJ, Chin YP, Nistor BJ, Hung H. Concentrations, gas-particle distributions, and sourceindicator analysis of brominated flame retardantsin air at Toolik Lake, Arctic Alaska. Environmental Science. Processes & Impacts 18, 1274-1284 (2016).
38. Gonzalez A, Avivar J, Cerda V. Estrogens determination in wastewater samples by automatic in-syringe dispersive liquid-liquid microextraction prior silylation and gas chromatography. J. Chromatogr. A 1413, 1-8 (2015).
39. Carroll JJ, Smith N, Babson AL. A colorimetric serum glucose determination using hexokinase and glucose-6-phosphate dehydrogenase. Biochem. Med. 4(2), 171-180 (1970).
40. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr. Studies of streptozotocin-induced insulitis and diabetes. Proc. Natl Acad. Sci. USA 74(6), 2485-2489 (1977).
41. Vavra JJ, Deboer C, Dietz A, Hanka LJ, Sokolski WT. Streptozotocin, a new antibacterial antibiotic. Antibiot. Annu. 7, 230-235 (1959).
42. Luna B, Feinglos MN. Drug-induced hyperglycemia. JAMA 286(16), 1945-1948 (2001).
43. O'connell SG, Haigh T, Wilson G, Anderson KA. An analytical investigation of 24 oxygenated-PAHs (OPAHs) using liquid and gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 405(27), 8885-8896 (2013).
44. Rappaport SM, Barupal DK, Wishart D, Vineis P, Scalbert A. The blood exposome and its role in discovering causes of disease. Environ. Health Perspect. 122(8), 769-774 (2014).
45. Dennis KK, Marder E, Balshaw DM et al. Biomonitoring in the era of the exposome. Environ. Health Perspect. doi:10. 1289/EHP474 (2016) (Epub ahead of print).
46. Ellis JK, Athersuch TJ, Thomas LD et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med. 10, 61 (2012).
47. Go YM, Walker DI, Liang Y et al. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol. Sci. 148(2), 531-543 (2015).
48. Southam AD, Lange A, Al-Salhi R, Hill EM, Tyler CR, Viant MR. Distinguishing between the metabolome and xenobiotic exposome in environmental field samples analysed by direct-infusion mass spectrometry based metabolomics and lipidomics. Metabolomics 10(6), 1050-1058 (2014).
49. Soltow QA, Strobel FH, Mansfield KG, Wachtman L, Park Y, Jones DP. High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DCFTMS) for study of the exposome. Metabolomics 9(Suppl. 1), S132-S143 (2013).
50. Johnson JM, Yu T, Strobel FH, Jones DP. A practical approach to detect unique metabolic patterns for personalized medicine. Analyst 135(11), 2864-2870 (2010).
51. Yao Y, Wang P, Shao G, Anzalota Del Toro LV, Codero J, Giese RW. Nontargeted analysis of the urine nonpolar sulfateome: A pathway to the nonpolar xenobiotic exposome. Rapid Commun. Mass Spectrom. 30(21), 2341-2350 (2016).
52. Park YH, Lee K, Soltow QA et al. High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. Toxicology 295(1-3), 47-55 (2012).
53. Schymanski EL, Singer HP, Longree P et al. Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. Environ. Sci. Technol. 48(3), 1811-1818 (2014).
54. Schymanski EL, Singer HP, Slobodnik J et al. Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis. Anal. Bioanal. Chem. 407(21), 6237-6255 (2015).
55. Ibanez M, Sancho JV, Mcmillan D, Rao R, Hernandez F. Rapid non-target screening of organic pollutants in water by ultraperformance liquid chromatography coupled to time-of-light mass spectrometry. Trends Analyt. Chem. 27(5), 481-489 (2008).
56. Hug C, Ulrich N, Schulze T, Brack W, Krauss M. Identification of novel micropollutants in wastewater by a combination of suspect and nontarget screening. Environ. Pollut. 184, 25-32 (2014).
57. Chiaia-Hernandez AC, Schymanski EL, Kumar P, Singer HP, Hollender J. Suspect and nontarget screening approaches to identify organic contaminant records in lake sediments. Anal. Bioanal. Chem. 406(28), 7323-7335 (2014).
58. Larive CK, Barding GA Jr, Dinges MM. NMR spectroscopy for metabolomics and metabolic profiling. Anal. Chem. 87(1), 133-146 (2014).
59. Dettmer K, Aronov PA, Hammock BD. Mass spectrometrybased metabolomics. Mass Spectrom. Rev. 26(1), 51-78 (2007).
60. Nagana Gowda GA, Gowda YN, Raftery D. Expanding the limits of human blood metabolite quantitation using NMR spectroscopy. Anal. Chem. 87(1), 706-715 (2014).
61. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78(13), 4430-4442 (2006).
62. Kopka J, Schauer N, Krueger S et al. GMD@CSB. DB: The Golm Metabolome Database. Bioinformatics 21(8), 1635-1638 (2005).
63. Vinaixa M, Schymanski EL, Neumann S, Navarro M, Salek RM, Yanes O. Mass spectral databases for LC/MS-and GC/MS-based metabolomics: state of the field and future prospects. Trends Analyt. Chem. 78, 23-35 (2016).
64. Hufsky F, Scheubert K, Bocker S. Computational mass spectrometry for small-molecule fragmentation. Trends Analyt. Chem. 53, 41-48 (2014).
65. Vaniya A, Fiehn O. Using fragmentation trees and mass spectral trees for identifying unknown compounds in metabolomics. Trends Analyt. Chem. 69, 52-61 (2015).
66. Ruttkies C, Schymanski EL, Wolf S, Hollender J, Neumann S. MetFrag relaunched: incorporating strategies beyond in silico fragmentation. J. Cheminform. 8, 3 (2016).
67. Sumner LW, Amberg A, Barrett D et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3(3), 211-221 (2007).
68. Wishart DS, Jewison T, Guo AC et al. HMDB 3. 0-The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-D807 (2013).
69. Singer HP, Wossner AE, Mcardell CS, Fenner K. Rapid screening for exposure to "non-target" pharmaceuticals from wastewater effluents by combining HRMS-based suspect screening and exposure modeling. Environ. Sci. Technol. 50(13), 6698-6707 (2016).
70. Moschet C, Piazzoli A, Singer H, Hollender J. Alleviating the reference standard dilemma using a systematic exact mass suspect screening approach with liquid chromatographyhigh resolution mass spectrometry. Anal. Chem. 85(21), 10312-10320 (2013).
71. NORMAN Suspect List Exchange. www. norman-network. com/?q=node/236
72. Schymanski EL, Jeon J, Gulde R et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ. Sci. Technol. 48(4), 2097-2098 (2014).
73. Suhr H. Plasma Chromatography. Plenum Press, NY, USA (1984).
74. Michelmann K, Silveira JA, Ridgeway ME, Park MA. Fundamentals of trapped ion mobility spectrometry. J. Am. Soc. Mass Spectrom. 26(1), 14-24 (2015).
75. Ewing MA, Conant CRP, Zucker SM, Griffith KJ, Clemmer DE. Selected overtone mobility spectrometry. Anal. Chem. 87(10), 5132-5138 (2015).
76. Zucker SM, Ewing MA, Clemmer DE. Gridless overtone mobility spectrometry. Anal. Chem. 85(21), 10174-10179 (2013).
77. Rus J, Moro D, Sillero JA et al. IMS-MS studies based on coupling a differential mobility analyzer (DMA) to commercial API-MS systems. Int. J. Mass Spectrom. 298(1-3), 30-40 (2010).
78. Brown LJ, Creaser CS. Field asymmetric waveform ion mobility spectrometry analysis of proteins and peptides: A review. Curr. Anal. Chem. 9(2), 192-198 (2013).
79. Guevremont R. High-field asymmetric waveform ion mobility spectrometry: A new tool for mass spectrometry. J. Chromatogr. 1058(1-2), 3-19 (2004).
80. Kolakowski BM, Mester Z. Review of applications of high-field asymmetric waveform ion mobility spectrometry (FAIMS) and differential mobility spectrometry (DMS). Analyst 132(9), 842-864 (2007).
81. Vidal-De-Miguel G, Macía M, Cuevas J. Transversal modulation ion mobility spectrometry (TM-IMS), a new mobility filter overcoming turbulence related limitations. Anal. Chem. 84(18), 7831-7837 (2012).
82. Hines KM, May JC, Mclean JA, Xu L. Evaluation of collision cross section calibrants for structural analysis of lipids by traveling wave ion mobility-mass spectrometry. Anal. Chem. 88(14), 7329-7336 (2016).
83. Suhr H. Plasma chromatography. In: Berichte der Bunsengesellschaft für physikalische Chemie, Carr TW (Ed.). Plenum Press, NY, USA, 924 (1984).
84. Mason EA, Mcdaniel EW. Transport Properties of Ions in Gases. John Wiley and Sons, NY, USA, 35 (1988).
85. Revercomb HE, Mason EA. Theory of plasma chromatography gaseous electrophoresis-review. Anal. Chem. 47(7), 970-983 (1975).
86. Kanu AB, Dwivedi P, Tam M, Matz L, Hill HH Jr. Ion mobility-mass spectrometry. J. Mass Spectrom. 43(1), 1-22 (2008).
87. May JC, Mclean JA. Ion mobility-mass spectrometry: Timedispersive instrumentation. Anal. Chem. 87(3), 1422-1436 (2015).
88. Williams JP, Bugarcic T, Habtemariam A et al. Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling. J. Am. Soc. Mass Spectrom. 20(6), 1119-1122 (2009).
89. Wu C, Siems WF, Klasmeier J, Hill HH. Separation of isomeric peptides using electrospray ionization/highresolution ion mobility spectrometry. Anal. Chem. 72(2), 391-395 (2000).
90. Kyle JE, Zhang X, Weitz KK et al. Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry. Analyst 141(5), 1649-1659 (2016).
91. Zheng X, Zhang X, Schocker N et al. Enhancing glycan isomer separations with metal ions and positive and negative polarity ion mobility spectrometry-mass spectrometry Anal. Bioanal. Chem. doi:10. 1007/s00216-016-9866-4 (2016) (Epub ahead of print).
92. Stephan S, Hippler J, Kohler T, Deeb AA, Schmidt TC, Schmitz OJ. Contaminant screening of wastewater with HPLC-IM-qTOF-MS and LC+LC-IM-qTOF-MS using a CCS database. Anal. Bioanal. Chem. 408(24), 6545-6555 (2016).
93. Fjeldsted J, Kurulugama RT, Mordehai A et al. Highly accurate collision cross section measurements for comprehensive high throughput applications. Presented at: 64th Annual Meeting of the American Society for Mass Spectrometry. San Antonio, TX, USA, June 5-9, 2016.
94. Causon TJ, Mairinger T, Hung LS et al. Addition of drift-tube ion mobility to liquid chromatography-mass spectrometry workflows: examining the potential for cellular metabolomics. Presented at: 12th Annual Conference of the Metabolomics Society. Dublin, Ireland, June 27-30, 2016.
95. Wyttenbach T, Bowers MT. Gas-phase conformations: The ion mobility/ion chromatography method. Mod. Mass Spectrom. 225, 207-232 (2003).
96. Baker ES, Clowers BH, Li F et al. Ion mobility spectrometrymass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J. Am. Soc. Mass Spectrom. 18(7), 1176-1187 (2007).
97. Liu X, Valentine SJ, Plasencia MD, Trimpin S, Naylor S, Clemmer DE. Mapping the human plasma proteome by SCX-LC-IMS-MS. J. Am. Soc. Mass Spectrom. 18(7), 1249-1264 (2007).
98. Baker ES, Livesay EA, Orton DJ et al. An LC-IMS-MS platform providing increased dynamic range for highthroughput proteomic studies. J. Proteome Res. 9(2), 997-1006 (2010).
99. Hoaglund CS, Valentine SJ, Sporleder CR, Reilly JP, Clemmer DE. Three-dimensional ion mobility/TOFMS analysis of electrosprayed biomolecules. Anal. Chem. 70(11), 2236-2242 (1998).
100. Baker ES, Zhang X, Burnum-Johnson KE et al. Enhancing ion mobility-mass spectrometry metabolomic analyses with high throughput front end separations. Presented at: The Pittsburgh Conference and Exposition. Atlanta, GA, USA, March 6-10, 2016.
101. Baker ES, Zhang X, Zheng X et al. Automated solid phase extractions coupled with ion mobility-mass spectrometry analyses allow rapid metabolomic screening of complex plasma and urine samples. Presented at: 64th Annual Meeting of the American Mass Spectrometry Society. San Antonio, TX, USA, June 5-9, 2016.
102. Kangas LJ, Metz TO, Isaac G et al. In silico identification software (ISIS): A machine learning approach to tandem mass spectral identification of lipids. Bioinformatics 28(13), 1705-1713 (2012).
103. Bauer CA, Grimme S. First principles calculation of electron ionization mass spectra for selected organic drug molecules. Org. Biomol. Chem. 12(43), 8737-8744 (2014).
104. Heller S, Mcnaught A, Stein S, Tchekhovskoi D, Pletnev I. InChI-the worldwide chemical structure identifier standard. J. Cheminform. 5(1), 7 (2013).
105. O'boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).
106. Halgren TA. Merck molecular force field. 1. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17(5-6), 490-519 (1996).
107. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4(1), 17 (2012).
108. Valiev M, Bylaska EJ, Govind N et al. NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations. Comput. Phys. Commun. 181(9), 1477-1489 (2010).
109. Hehre WJ, Ditchfie R, Pople JA. Self-consistent molecularorbital methods. 12. Further extensions of gaussian-type basis sets for use in molecular-orbital studies of organicmolecules. J. Chem. Phys. 56(5), 2257 (1972).
110. Stephens PJ, Devlin FJ, Chabalowski CF, Frisch MJ. Abinitio calculation of vibrational absorption and circulardichroism spectra using density-functional force-fields. J. Phys. Chem. 98(45), 11623-11627 (1994).
111. Becke AD. Density-functional thermochemistry. 3. The role of exact exchange. J. Chem. Phys. 98(7), 5648-5652 (1993).
112. Shvartsburg AA, Jarrold MF. An exact hard-spheres scattering model for the mobilities of polyatomic ions. Chem. Phys. Lett. 261(1-2), 86-91 (1996).
113. Campuzano I, Bush MF, Robinson CV et al. Structural characterization of drug-like compounds by ion mobility mass spectrometry: comparison of theoretical and experimentally derived nitrogen collision cross sections. Anal. Chem. 84(2), 1026-1033 (2012).
114. Mesleh MF, Hunter JM, Shvartsburg AA, Schatz GC, Jarrold MF. Structural information from ion mobility measurements: effects of the long-range potential. J. Phys. Chem. 100(40), 16082-16086 (1996).
115. Marklund EG, Degiacomi MT, Robinson CV, Baldwin AJ, Benesch JL. Collision cross sections for structural proteomics. Structure 23(4), 791-799 (2015).
116. Von Helden G, Kemper PR, Gotts NG, Bowers MT. Isomers of small carbon cluster anions: linear chains with up to 20 atoms. Science 259(5099), 1300-1302 (1993).
117. Paglia G, Williams JP, Menikarachchi L et al. Ion mobility derived collision cross sections to support metabolomics applications. Anal. Chem. 86(8), 3985-3993 (2014).
118. Rokushika S, Hatano H, Baim MA, Hill HH. Resolution measurement for ion mobility spectrometry. Anal. Chem. 57(9), 1902-1907 (1985).
119. Deng L, Ibrahim YM, Hamid AM et al. Ultra-high resolution ion mobility separations utilizing traveling waves in a 13-m serpentine path length structures for lossless ion manipulations module. Anal. Chem. 88(18), 8957-8964 (2016).
120. Knapman TW, Berryman JT, Campuzano I, Harris SA, Ashcroft AE. Considerations in experimental and theoretical collision cross-section measurements of small molecules using travelling wave ion mobility spectrometry-mass spectrometry. Int. J. Mass spectrom. 298(1-3), 17-23 (2010).
121. Ridenour WB, Kliman M, Mclean JA, Caprioli RM. Structural characterization of phospholipids and peptides directly from tissue sections by MALDI traveling-wave ion mobility-mass spectrometry. Anal. Chem. 82(5), 1881-1889 (2010).
122. Bush MF, Hall Z, Giles K, Hoyes J, Robinson CV, Ruotolo BT. Collision cross sections of proteins and their complexes: A calibration framework and database for gas-phase structural biology. Anal. Chem. 82(22), 9557-9565 (2010).
123. Gelb AS, Jarratt RE, Huang Y, Dodds ED. A study of calibrant selection in measurement of carbohydrate and peptide ion-neutral collision cross sections by traveling wave ion mobility spectrometry. Anal. Chem. 86(22), 11396-11402 (2014).
124. Deng L, Ibrahim YM, Hamid AM et al. Ultra-high resolution ion mobility separations utilizing traveling waves in a 13-m serpentine path length structures for lossless ion manipulations module. Anal. Chem. 88(18), 8957-8964 (2016).
125. Metz TO, Page JS, Baker ES et al. High resolution separations and improved ion production and transmission in metabolomics. Trends Analyt. Chem. 27(3), 205-214 (2008).